Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women.

Wu Y, Sarkissyan M, Clayton S, Chlebowski R, Vadgama JV.

Cancers (Basel). 2017 Oct 24;9(10). pii: E144. doi: 10.3390/cancers9100144.

2.

Serum Vitamin D and Risk of Breast Cancer within Five Years.

O'Brien KM, Sandler DP, Taylor JA, Weinberg CR.

Environ Health Perspect. 2017 Jul 6;125(7):077004. doi: 10.1289/EHP943.

3.

Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.

Eliassen AH, Warner ET, Rosner B, Collins LC, Beck AH, Quintana LM, Tamimi RM, Hankinson SE.

Cancer Res. 2016 Sep 15;76(18):5423-30. doi: 10.1158/0008-5472.CAN-16-0353. Epub 2016 Aug 16.

4.

Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women.

Palmer JR, Gerlovin H, Bethea TN, Bertrand KA, Holick MF, Ruiz-Narvaez EN, Wise LA, Haddad SA, Adams-Campbell LL, Kaufman HW, Rosenberg L, Cozier YC.

Breast Cancer Res. 2016 Aug 12;18(1):86. doi: 10.1186/s13058-016-0745-x.

5.

Calibration and seasonal adjustment for matched case-control studies of vitamin D and cancer.

Gail MH, Wu J, Wang M, Yaun SS, Cook NR, Eliassen AH, McCullough ML, Yu K, Zeleniuch-Jacquotte A, Smith-Warner SA, Ziegler RG, Carroll RJ.

Stat Med. 2016 Jun 15;35(13):2133-48. doi: 10.1002/sim.6856. Epub 2016 Jan 5.

6.

Nucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer Therapy.

Pawlowska E, Wysokinski D, Blasiak J.

Int J Mol Sci. 2016 Apr 6;17(4):372. doi: 10.3390/ijms17040372. Review.

7.

Vitamin D intake, month the mammogram was taken and mammographic density in Norwegian women aged 50-69.

Ellingjord-Dale M, dos-Santos-Silva I, Grotmol T, Sakhi AK, Hofvind S, Qureshi S, Markussen MS, Couto E, Vos L, Ursin G.

PLoS One. 2015 May 4;10(5):e0123754. doi: 10.1371/journal.pone.0123754. eCollection 2015.

8.

Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.

Bertrand KA, Rosner B, Eliassen AH, Hankinson SE, Rexrode KM, Willett W, Tamimi RM.

Breast Cancer Res Treat. 2015 Jan;149(2):479-87. doi: 10.1007/s10549-014-3247-5. Epub 2014 Dec 28.

9.

Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II.

Wang J, Eliassen AH, Spiegelman D, Willett WC, Hankinson SE.

Cancer Causes Control. 2014 Jul;25(7):819-27. doi: 10.1007/s10552-014-0383-5. Epub 2014 Apr 20.

10.

Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.

Kim Y, Je Y.

Br J Cancer. 2014 May 27;110(11):2772-84. doi: 10.1038/bjc.2014.175. Epub 2014 Apr 8.

11.

Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study.

Kim Y, Franke AA, Shvetsov YB, Wilkens LR, Cooney RV, Lurie G, Maskarinec G, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN, Goodman MT.

BMC Cancer. 2014 Jan 17;14:29. doi: 10.1186/1471-2407-14-29.

12.

Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.

Bauer SR, Hankinson SE, Bertone-Johnson ER, Ding EL.

Medicine (Baltimore). 2013 May;92(3):123-31. doi: 10.1097/MD.0b013e3182943bc2. Review.

13.

Vitamin d: are we ready to supplement for breast cancer prevention and treatment?

Crew KD.

ISRN Oncol. 2013;2013:483687. doi: 10.1155/2013/483687. Epub 2013 Feb 26.

14.

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.

Scarmo S, Afanasyeva Y, Lenner P, Koenig KL, Horst RL, Clendenen TV, Arslan AA, Chen Y, Hallmans G, Lundin E, Rinaldi S, Toniolo P, Shore RE, Zeleniuch-Jacquotte A.

Breast Cancer Res. 2013 Feb 26;15(1):R15. doi: 10.1186/bcr3390.

15.

Correlates of 25-hydroxyvitamin D and breast cancer stage in the Women's Healthy Eating and Living Study.

Jacobs ET, Thomson CA, Flatt SW, Newman VA, Rock CL, Pierce JP.

Nutr Cancer. 2013;65(2):188-94. doi: 10.1080/01635581.2013.756531.

16.

Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies.

Chen P, Li M, Gu X, Liu Y, Li X, Li C, Wang Y, Xie D, Wang F, Yu C, Li J, Chen X, Chu R, Zhu J, Ou Z, Wang H.

PLoS One. 2013;8(1):e49312. doi: 10.1371/journal.pone.0049312. Epub 2013 Jan 30.

17.

Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria?

Mohr SB, Gorham ED, Alcaraz JE, Kane CI, Macera CA, Parsons JK, Wingard DL, Garland CF.

Dermatoendocrinol. 2012 Apr 1;4(2):152-7. doi: 10.4161/derm.20449.

18.

Vitamin D and the mammary gland: a review on its role in normal development and breast cancer.

Lopes N, Paredes J, Costa JL, Ylstra B, Schmitt F.

Breast Cancer Res. 2012 May 31;14(3):211. Review.

19.

Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.

Swami S, Krishnan AV, Wang JY, Jensen K, Horst R, Albertelli MA, Feldman D.

Endocrinology. 2012 Jun;153(6):2576-87. doi: 10.1210/en.2011-1600. Epub 2012 Mar 27.

20.

25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1.

Amir E, Cecchini RS, Ganz PA, Costantino JP, Beddows S, Hood N, Goodwin PJ.

Breast Cancer Res Treat. 2012 Jun;133(3):1077-88. doi: 10.1007/s10549-012-2012-x. Epub 2012 Mar 14. Erratum in: Breast Cancer Res Treat. 2012 Oct;135(3):923.

Supplemental Content

Support Center